Botox vs. Fillers: They Do Completely Different Things

These two get lumped together as “injectables” and discussed as if you are choosing between them. You are usually not. They address different causes, in different parts of the face, by entirely different mechanisms. Most people who use both are using them in different places for different reasons.

At a glance

	Botox / Neuromodulators	Dermal Fillers
What it is	Botulinum toxin type A (Botox, Dysport, Xeomin, Jeuveau, Daxxify)	A gel — most commonly hyaluronic acid (Juvéderm, Restylane, RHA); also calcium hydroxylapatite, poly-L-lactic acid
Mechanism	Temporarily blocks the nerve signal to a muscle; the muscle stops contracting	Physically occupies space under the skin, adding volume or lifting a fold
What it treats	Dynamic lines — creases caused by movement: frown lines (glabella), horizontal forehead lines, crow’s feet. Also masseter slimming, gummy smile, excessive sweating	Static volume loss — hollow cheeks, under-eye hollows (tear trough), nasolabial folds, marionette lines, thin lips, weak chin or jawline
What it does not treat	Volume loss, hollowing, sagging, skin texture, sun damage	Lines caused purely by muscle movement; skin laxity of any real degree
Onset	3–7 days to begin, ~2 weeks for full effect	Immediate (though swelling obscures the true result for 1–2 weeks)
Longevity	~3–4 months	~6–18 months, depending on product and site
Typical cost (ASPS 2024 national averages)	~$435 per session (neuromodulator injection)	~$698 (lip augmentation with HA filler); per-syringe pricing commonly $600–$1,000+
Reversible?	No — but it wears off	HA fillers are reversible with hyaluronidase, an enzyme that dissolves them. Non-HA fillers largely are not
Main risks	Temporary eyelid or brow droop, asymmetry, headache, bruising — all resolve	Bruising, swelling, lumps, nodules; rarely, vascular occlusion causing tissue necrosis or, very rarely, blindness

Cost figures are national averages published by the American Society of Plastic Surgeons for 2024. Injectable pricing varies enormously by market, by unit versus per-area pricing, and by injector. Treat them as reference points, not quotes.

The test that tells you which one you need

Stand in front of a mirror with a relaxed face.

Do the lines disappear? If a crease vanishes when your face is completely still and only appears when you frown, raise your brows, or smile, it is a dynamic line caused by muscle contraction. That is Botox territory.

Are the lines still there when you are relaxed? If the hollow under your eye, the fold from your nose to the corner of your mouth, or the flatness of your cheek is present with a completely still face, it is a static problem caused by volume loss and tissue descent. That is filler territory. Relaxing a muscle will not fill a hollow.

Deeply etched lines that are still visible at rest but get much worse with movement — a very common finding in the glabella, the frown area between the brows — are the mixed case. These often need the muscle relaxed and the etched crease addressed, sometimes over multiple treatment cycles. The muscle relaxation prevents further deepening; the surface line may also need resurfacing or, in some cases, a small amount of filler placed with considerable care.

Where each actually goes

Upper face → mostly Botox. The frown lines between the brows, horizontal forehead lines, and crow’s feet at the outer corners of the eyes are the three FDA-approved cosmetic indications for Botox, and they are the areas where neuromodulators are most reliable and most predictable.

Mid and lower face → mostly filler. Cheeks, tear troughs, nasolabial folds, marionette lines, lips, chin, jawline. These are volume and structure problems.

There are crossovers — Botox for a downturned mouth corner, for a “gummy” smile, for masseter slimming, for platysmal neck bands; filler for a non-surgical rhinoplasty or temple hollowing — but the map above holds for the vast majority of treatments.

The safety asymmetry nobody talks about enough

This is the part worth reading twice.

Botox complications are temporary. A poorly placed injection can drop an eyelid or a brow, or produce asymmetry. It is genuinely distressing and it can last for weeks. But it resolves, because the product wears off. There is no permanent injury.

Filler complications can be permanent. The serious one is vascular occlusion — filler injected into, or pressing on, an artery. If it blocks blood supply to skin, that tissue can die. If it enters an artery that connects to the ocular circulation — a real anatomical risk, particularly in the glabella, the nose, and the tear trough — it can cause blindness. This is rare. It is also irreversible, and it is entirely dependent on the injector’s knowledge of facial vascular anatomy and their ability to recognize and treat an occlusion within minutes.

The practical implications:

• The injector matters far more for filler than for Botox. Ask who is injecting, what their training is, and what their experience is with the specific area being treated.
• Ask if hyaluronidase is on the premises. It is the enzyme that dissolves HA filler and is the emergency treatment for occlusion. A clinic injecting HA filler without hyaluronidase immediately at hand is not one to use. This is a fair and standard question.
• Prefer HA filler if you are new to it, precisely because it is reversible. Non-HA fillers and any permanent filler raise the stakes on every decision.
• Be especially cautious around the eyes and nose. The tear trough and non-surgical rhinoplasty are among the highest-risk filler sites and should be done by someone who does them frequently.

Cost and the honest math

Botox is usually priced per unit (a typical glabella treatment might use around 20 units) or per area. Per-unit pricing is more transparent; per-area pricing can conceal an under-dose that wears off early. Ask which model you are being quoted, and how many units you actually received.

Filler is priced per syringe. One syringe is a small amount — about a teaspoon. Meaningful cheek restoration frequently requires several. A quote of “one syringe” for a face that needs four is not a bargain; it is an under-treatment.

Both are recurring costs. Botox at three-to-four-month intervals is three to four treatments a year, indefinitely. Filler at six-to-eighteen-month intervals is less frequent but more expensive per visit. Over a decade, injectables can total more than a surgical procedure — which is a legitimate thing to weigh, not an argument for surgery, but a number worth actually running.

When neither is the answer

If your concern is sagging — jowls, loose neck skin, hooded eyelids — injectables cannot fix it. Filler chasing significant laxity produces the overfilled, heavy, distorted look that people rightly find unsettling. It is added weight on tissue that is already descending. The answer for sagging is surgical.

If your concern is skin quality — texture, pigmentation, sun damage, fine crepey lines — neither Botox nor filler addresses it. That is resurfacing, topical medical skincare, and sun protection.

The best injectable outcomes come from correctly matching the tool to the problem, using a conservative amount, and having it done by someone who knows what is underneath the needle.